Stem Cell Research (Oct 2022)

Generation of induced pluripotent stem cell lines from three patients with Aicardi-Goutières syndrome type 5 due to biallelic SAMDH1 mutations

  • Vanessa Hänchen,
  • Stefanie Kretschmer,
  • Christine Wolf,
  • Kerstin Engel,
  • Shahryar Khattak,
  • Katrin Neumann,
  • Min Ae Lee-Kirsch

Journal volume & issue
Vol. 64
p. 102912

Abstract

Read online

Mutations in SAMHD1, encoding SAM and HD domain-containing protein 1, cause Aicardi-Goutières syndrome (AGS) 5, an infancy-onset autoinflammatory disease characterized by neurodegeneration and chronic activation of type I interferon. Here, we report the generation and characterization of induced pluripotent stem cells (iPSCs) derived from fibroblasts and peripheral blood mononuclear cells from three AGS patients with biallelic SAMHD1 mutations. These cell lines provide a valuable source to study disease mechanisms and to assess therapeutic molecules.